Status:

UNKNOWN

Pregnancy-Induced Analgesia - A Longitudinal Study of DNIC

Lead Sponsor:

University of Washington

Collaborating Sponsors:

Stanford University

Conditions:

Pregnancy

Eligibility:

FEMALE

18-45 years

Brief Summary

The investigators hypothesize that pregnancy-induced analgesia might be the result of enhanced descending noxious inhibitory activity.

Detailed Description

Pregnancy-induced analgesia has been described in several studies (Gintzler 1980; Sander and Gintzler 1987; Jarvis et al. 1997). Obvious mechanisms underlying pregnancy-induced analgesia involve hormo...

Eligibility Criteria

Inclusion

  • Pregnant Cohort: Inclusion criteria for participation are (1) women aged between 18 and 45 yr, (2) nulliparous or ASA physical status class I or II women, (3) singleton pregnancy, (4) no more than 14 completed weeks gestational age at the time of enrollment into the study, (5) uncomplicated pregnancy, and (6) delivery planned to be conducted at UW/Stanford University.
  • Non-pregnant Control Cohort: Inclusion criteria for participation are (1) women aged between 18 and 45 yr, (2) nulliparous or ASA physical status class I or II women, (3) and not planning on taking oral-contraceptives or carrying a hormonal-coated IUD.
  • Non-inclusion Criteria:
  • Pregnant Cohort: Non-inclusion criteria are (1) multiparous women, (2) non-English speaking women (subjects have to be able to understand the DNIC procedure and answer questionnaires), (3) women unable to understand the concept of VNPS at the time of informed consent (involving mental health issues), (4) a history of anxiety or depression, or chronic consumption of opiates, antidepressants, or anticonvulsants; and (5) intake of opioids, acetaminophen, or NSAIDs 48h prior to the psychophysical test.
  • Non-pregnant Control Cohort: Non-inclusion criteria are the same as the Pregnant Cohort as well as (6) irregular menstrual cycles (defined as \< 21 days or \> 35 days).

Exclusion

  • Pregnant Cohort: Exclusion criteria is a pregnancy complicated by preeclampsia or preterm delivery (\< 37 weeks gestation).
  • Non-pregnant Control Cohort: Exclusion criteria is development of irregular cycles.

Key Trial Info

Start Date :

March 1 2009

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2013

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00867945

Start Date

March 1 2009

End Date

December 1 2013

Last Update

June 19 2013

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Stanford University School of Medicine

Stanford, California, United States, 94305

2

University of Washington

Seattle, Washington, United States, 98195-6540